From: Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol
No resection
Resection
Not recommended for surgery based on multi-omics
A (e.g. 54)
C (e.g. 6)
A + C
Recommended to proceed to surgery based on multi-omics
B (e.g. 6)
D (e.g. 34)
B + D
A + B (60)
C + D (40)
A + B + C + D